OTCM
GPINF
, Last price
USD
Name
Steep Hill Inc
Chart & performance
P/E
—
P/S
—
EPS
0.00
Vol. 1Y
—
Shs. 5Y
58.71%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
Net income
338k
-57.43%
CFO
-381k
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Toronto, Canada, in 2008, Steep Hill Inc. operates as a leading science and technology firm dedicated to the cannabis sector. The company delivers an extensive range of services throughout Canada and the United States, including sophisticated laboratory analysis, thorough quality assurance, and insightful data analytics. Its testing capabilities cover a broad spectrum, assessing cannabinoids, terpenes, pesticides, mycotoxins, heavy metals, and residual solvents. Additionally, Steep Hill conducts microbial examinations, foreign material screenings, and evaluates moisture levels, water activity, vitamin E acetate presence, and product uniformity, alongside comprehensive hemp assessments. Beyond its testing facilities, the organization offers specialized consulting regarding analytical methodologies, cannabis industry regulations, specific testing protocols, laboratory information management systems (LIMS), and overarching product integrity and safety. The entity rebranded to Steep Hill Inc. in February 2022, having previously operated as Cannabis Clonal Corporation.
Headquarters & legal address
Adelaide St. West 120
Toronto, ON M5H 1T1
CA
Toronto, ON M5H 1T1
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||